Development

An AI-designed antibody clears early safety and draws a $100M round

development2026-06-26

Claim

Absci jumped 24% on early safety data for its AI-designed hair-loss antibody, drawing a $100 million round led by Eli Lilly that also bets on an endometriosis treatment.

Reported metric: $100M round

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Knowledge graphopen in browser →

Reported in
Actor
Evidence for
Supersedes
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.